The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease

Molecular Neurodegeneration

Volumn 10, Issue 1, 2015, Pages

  Mata, Ignacio F ^a,b   Jang, Yongwoo ^c   Kim, Chun Hyung ^c   Hanna, David S ^b,d   Dorschner, Michael O ^b,d   Samii, Ali ^a,b   Agarwal, Pinky ^e   Roberts, John W ^f   Klepitskaya, Olga ^g   Shprecher, David R ^h   Chung, Kathryn A ^i,j   Factor, Stewart A ^k   Espay, Alberto J ^l   Revilla, Fredy J ^m   Higgins, Donald S ⁿ   Litvan, Irene ^o   Leverenz, James B ^p   Yearout, Dora ^a,b   Inca Martinez, Miguel ^q   Martinez, Erica ^a,b   Thompson, Tiffany R ^a   Cholerton, Brenna A ^a,b   Hu, Shu Ching ^a,b   Edwards, Karen L ^r   Kim, Kwang Soo ^c   Zabetian, Cyrus P ^a,b   more..

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c MCLEAN HOSPITAL   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Evergreen Hospital Medical Center   (United States)

^f VIRGINIA MASON MEDICAL CENTER   (United States)

^g UNIVERSITY OF COLORADO   (United States)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁱ PORTLAND VA MEDICAL CENTER   (United States)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^m UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE GREENVILLE   (United States)

ⁿ STRATTON VA MEDICAL CENTER   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p LERNER RESEARCH INSTITUTE   (United States)

^q INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

^r UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; MUTANT PROTEIN; RAB PROTEIN; RAB39B PROTEIN; UNCLASSIFIED DRUG; RAB39B PROTEIN, HUMAN;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; MISSENSE MUTATION; ONSET AGE; PARKINSON DISEASE; PEDIGREE ANALYSIS; PENETRANCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RAB39B GENE; X CHROMOSOME DOMINANT INHERITANCE; ANIMAL; EXOME; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MUTATION; PHENOTYPE; RAT;

ADULT; AGE OF ONSET; ANIMALS; EXOME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PHENOTYPE; RAB GTP-BINDING PROTEINS; RATS;

EID: 84958520687     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/s13024-015-0045-4     Document Type: Article

References (23)

1. Trinh J, Farrer M. Advances in the genetics of Parkinson disease. Nat Rev Neurol. 2013;9(8):445-54.
2. Singleton AB. Exome sequencing: a transformative technology. Lancet Neurol. 2011;10(10):942-6.
3. Zimprich A, Benet-Pages A, Struhal W, Graf E, Eck SH, Offman MN, et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet. 2011;89(1):168-75.
4. Vilarino-Guell C, Rajput A, Milnerwood AJ, Shah B, Szu-Tu C, Trinh J, et al. DNAJC13 mutations in Parkinson disease. Hum Mol Genet. 2014;23(7):1794-801.
5. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745-52.
6. Weeke P, Mosley JD, Hanna D, Delaney JT, Shaffer C, Wells QS, et al. Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome. J Am Coll Cardiol. 2014;63(14):1430-7.
7. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S, et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science. 2012;337(6090):64-9.
8. Carson AR, Smith EN, Matsui H, Braekkan SK, Jepsen K, Hansen JB, et al. Effective filtering strategies to improve data quality from population-based whole exome sequencing studies. BMC Bioinformatics. 2014;15:125.
9. Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310-5.
10. Ferreira JP, Peacock RW, Lawhorn IE, Wang CL. Modulating ectopic gene expression levels by using retroviral vectors equipped with synthetic promoters. Syst Synth Biol. 2011;5(3-4):131-8.
11. Giannandrea M, Bianchi V, Mignogna ML, Sirri A, Carrabino S, D'Elia E, et al. Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly. Am J Hum Genet. 2010;86(2):185-95.
12. Vanmarsenille L, Giannandrea M, Fieremans N, Verbeeck J, Belet S, Raynaud M, et al. Increased dosage of RAB39B affects neuronal development and could explain the cognitive impairment in male patients with distal Xq28 copy number gains. Hum Mutat. 2014;35(3):377-83.
13. Wilson GR, Sim JC, McLean C, Giannandrea M, Galea CA, Riseley JR, et al. Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with alpha-synuclein pathology. Am J Hum Genet. 2014;95(6):729-35.
14. Hutagalung AH, Novick PJ. Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev. 2011;91(1):119-49.
15. Schwartz SL, Cao C, Pylypenko O, Rak A, Wandinger-Ness A. Rab GTPases at a glance. J Cell Sci. 2007;120(Pt 22):3905-10.
16. Pfeffer SR. Structural clues to Rab GTPase functional diversity. J Biol Chem. 2005;280(16):15485-8.
17. Moritz OL, Tam BM, Hurd LL, Peranen J, Deretic D, Papermaster DS. Mutant rab8 Impairs docking and fusion of rhodopsin-bearing post-Golgi membranes and causes cell death of transgenic Xenopus rods. Mol Biol Cell. 2001;12(8):2341-51.
18. Mignogna ML, Giannandrea M, Gurgone A, Fanelli F, Raimondi F, Mapelli L, et al. The intellectual disability protein RAB39B selectively regulates GluA2 trafficking to determine synaptic AMPAR composition. Nat Commun. 2015;6:6504.
19. Cingolani P, Platts A, le Wang L, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6(2):80-92.
20. Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, et al. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology. 2012;79(19):1944-50.
21. Kim CH, Leung A, Huh YH, Yang E, Kim DJ, Leblanc P, et al. Norepinephrine deficiency is caused by combined abnormal mRNA processing and defective protein trafficking of dopamine beta-hydroxylase. J Biol Chem. 2011;286(11):9196-204.
22. Jang Y, Lee MH, Lee J, Jung J, Lee SH, Yang DJ, et al. TRPM2 mediates the lysophosphatidic acid-induced neurite retraction in the developing brain. Pflugers Arch. 2014;466(10):1987-98.
23. Kelley LA, Sternberg MJ. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc. 2009;4(3):363-71.